Own A2 Milk shares? Here's how the company is battling to rebuild lost daigou sales

The milk and infant formula company has a plan to revive its fortunes.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • A2 Milk shares have lifted over the past month
  • Despite the reported loss of one major daigou customer, A2 Milk has a rebuilding plan 
  • In further news, the company is reportedly on the verge of FDA approval to sell its infant formula products in the US 

A2 Milk Company Ltd (ASX: A2M) shares climbed last month, despite one major daigou customer reportedly cutting ties.

The baby infant formula company's share price lifted nearly 12% since market close on 1 July to end the month at $4.90. For perspective, the S&P/ASX 200 Index (ASX: XJO) gained 7% in the same time frame.

Let's take a look at what is going on with A2 Milk.

Young girl drinking milk showing off muscles.

Image source: Getty Images

What's going on at A2 Milk

A2 Milk has lost one major corporate daigou customer, however, this is not stopping the company exploring other avenues to export its product.

'Daigou' refers to people or groups who export luxury goods, including infant formulas, from outside China to customers in China.

Wenjun Zhang was previously A2 Milk's top customer, according to the Australian Financial Review, but has not bought any product since March.

However, A2 Milk CEO David Bortolussi outlined how the company is rebuilding. In comments cited by the publication, he said:

During the past year, we have increased our direct engagement with the daigou community, provided more marketing support and seen an increasing number of daigou representing our a2 Platinum brand.

Consistent with our growth strategy communicated to the market last year, we are simplifying and delayering our English Label infant milk formula distribution network.

On Tuesday, A2 Milk shares shot up more than 7% amid speculation the US Food and Drug Administration (FDA) would approve A2 Milk to sell infant formula products in the US. However, in an announcement to the market, A2 Milk said:

The company wishes to confirm that while we have been informed by the FDA that our application is under active review, at this stage there is no certainty as to the outcome of the application or the timing of any approval.

Share price snapshot

A2 Milk shares have lost almost 17% in the past year and more than 9% year to date.

For perspective, the ASX 200 Index has dropped around 6% so far in 2022.

A2 Milk has a market capitalisation of about $3.6 billion based on the current share price.

Motley Fool contributor Monica O'Shea has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Consumer Staples & Discretionary Shares

a cute small baby wearing a chinese embroidered outfit looks intently with hands outstretched as a hand holds a bottle of infant formula to his mouth.
Consumer Staples & Discretionary Shares

Baby Bunting FY26 earnings: Profit surges as margins hit a record

Baby Bunting posts strong FY26 profit growth and expands margin as refurbishment program boosts sales.

Read more »

son playing game on iPad with dad watching netflix
Consumer Staples & Discretionary Shares

Ainsworth Game Technology inks major patent deal with Aristocrat

Ainsworth Game Technology strikes a major patent licence deal with Aristocrat to support its Australian growth ambitions.

Read more »

A woman wine tasting in a bottle shop.
Earnings Results

Treasury Wine Estates FY26 earnings: Transformation continues amid US asset write-downs

EBITS was up 19.2% to $492.3 million, beating its guidance.

Read more »

A couple sit in front of a laptop reading ASX shares news articles and learning about ASX 200 bargain buys
Consumer Staples & Discretionary Shares

Bapcor reaffirms FY26 EBITDA guidance

Bapcor has confirmed its FY26 underlying EBITDA guidance, providing further clarity for investors.

Read more »

a woman looks at her phone while making a transaction at the counter of a store where racks of clothing can be seen in the background.
Earnings Results

Premier Investments updates investors on FY26 sales and outlook

Premier Retail sales are down in FY 2026.

Read more »

Smiling man at the wheel of a car.
Earnings Results

Amotiv Ltd FY26 earnings steady, dividend lifted

The auto parts retailer is paying a full year dividend of 43 cents per share.

Read more »

A man and woman watch their device screens, making investing decisions at home.
Consumer Staples & Discretionary Shares

Accent Group share price in focus as Frasers releases updated bidder's statement

The Accent Group share price is in focus after Frasers released a supplementary bidder’s statement challenging Accent’s value assessment.

Read more »

Woman sits cross legged on bed drinking a glass of wine and holding TV remote control.
Consumer Staples & Discretionary Shares

Treasury Wine Estates writes down US assets, posts higher FY26 EBITS

The wine giant has announced a further $558.4 million post-tax non-cash write-down on its US assets.

Read more »